The Prostate Cancer Foundation has been a major catalyst for many of the scientific advances in prostate cancer research since 1993. PCF has awarded more than 2,000 projects that offer hope for improving outcomes in patients with prostate cancer. These high-impact projects include clinical research to evaluate new drugs, novel treatment strategies for prostate cancer and basic scientific research to better understand the biology of prostate cancer.
Ranging from $300,000 to $1,500,000 per year for 3 years, these awards will cover direct costs of the research. Teams may be assembled from one institution, or from several institutions and should be comprised of at least three highly experienced investigators capable of providing unique scientific expertise to the solution of a significant problem in prostate cancer research.
These two year awards for $300,000 support exceptionally novel projects with great potential to produce breakthroughs for detecting and treating prostate cancer. They are complementary and integrated with other PCF award programs.
The Young Investigator Awards offer career and project support for young (generally 35 and younger) proven investigators in postdoctoral fellowships or who have recently achieved junior faculty positions and are committing their lives to the field of prostate cancer.
PCF and its partners grant awards that recognize top presentations at international cancer research meetings. Recognition Awards go to investigators not currently funded by PCF who have a record of outstanding accomplishments in prostate cancer research.
What This Means for Science and Patients: This proposed Challenge Award’s findings will translate directly to patients survivability, facilitating an improved standard of care and solidifying the next level of...